— Know what they know.
Not Investment Advice

PRPH OTC

ProPhase Labs, Inc.
1W: +43.6% 1M: -21.8% 3M: -78.5% YTD: -95.6% 1Y: -99.7% 3Y: -99.9% 5Y: -99.9%
$0.02
+0.00 (+31.67%)
 
Weekly Expected Move ±35.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 44 · $221456 mcap · 14M float · 1.12% daily turnover · Short 34% of daily vol

📊 Key Metrics

TTM
$3M
Revenue
-5.5% YoY
$-23M
Net Income
+45.4% YoY
$-5M
Free Cash Flow
+9.0% YoY
22.4%
Gross Margin
-261.6%
Op. Margin
-301.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-544.0%
ROA-45.5%
ROIC-207.6%

Valuation

P/E-0.0
P/B-0.1
EV/EBITDA-1.4

Leverage

Debt/Equity-2.93
Current Ratio0.05
Interest Cov.-2.1x

Quality Scores

Piotroski F3/9
Altman Z-3.95
Beneish M-3.20

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms